Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Details for Australian Patent Application No. 2009244325 (hide)

Owner Allergan, Inc.

Inventors Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009244325

PCT Pub. Number WO2009/137544

Priority 61/051,817 09.05.08 US

Filing date 6 May 2009

Wipo publication date 12 November 2009

International Classifications

C07D 333/32 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137544 Priority application(s): WO2009/137544

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244341-Method of measuring effects of components on cell reactive oxygen species production

2009244318-Signal operated tools for milling, drilling, and/or fishing operations